BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12796400)

  • 1. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
    Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
    Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history.
    Keller G; Rudelius M; Vogelsang H; Grimm V; Wilhelm MG; Mueller J; Siewert JR; Höfler H
    Am J Pathol; 1998 May; 152(5):1281-9. PubMed ID: 9588896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
    Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
    Clin Cancer Res; 2001 May; 7(5):1343-9. PubMed ID: 11350904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features.
    Napieralski R; Ott K; Kremer M; Becker K; Boulesteix AL; Lordick F; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2007 Sep; 13(17):5095-102. PubMed ID: 17785563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy.
    Nakayama S; Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Fukumoto M; Miyazaki K
    Int J Mol Med; 2003 May; 11(5):621-5. PubMed ID: 12684700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
    Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL
    Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
    Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
    J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
    Righetti SC; Della Torre G; Pilotti S; Ménard S; Ottone F; Colnaghi MI; Pierotti MA; Lavarino C; Cornarotti M; Oriana S; Böhm S; Bresciani GL; Spatti G; Zunino F
    Cancer Res; 1996 Feb; 56(4):689-93. PubMed ID: 8630996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
    Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
    Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.
    Gazvoda B; Juvan R; Zupanic-Pajnic I; Repse S; Ferlan-Marolt K; Balazic J; Komel R
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1082-9. PubMed ID: 17998833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal and microsatellite instability in sporadic gastric cancer.
    Hiyama T; Tanaka S; Yoshihara M; Sasao S; Kose K; Shima H; Tuncel H; Ueno Y; Ito M; Kitadai Y; Yasui W; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2004 Jul; 19(7):756-60. PubMed ID: 15209621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the p53 gene mutation and microsatellite instability of gastric carcinoma].
    Guo W; Zhang Y; Wu B; Zhang L; Zhou D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):101-4. PubMed ID: 10751531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer.
    Matsuzaki K; Deng G; Tanaka H; Kakar S; Miura S; Kim YS
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8564-9. PubMed ID: 16361538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway.
    van Rees BP; Caspers E; zur Hausen A; van den Brule A; Drillenburg P; Weterman MA; Offerhaus GJ
    Am J Pathol; 2002 Oct; 161(4):1207-13. PubMed ID: 12368194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
    Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
    Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma.
    Handra-Luca A; Hernandez J; Mountzios G; Taranchon E; Lacau-St-Guily J; Soria JC; Fouret P
    Clin Cancer Res; 2007 Jul; 13(13):3855-9. PubMed ID: 17606717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inheritance instability of chromosome 6q in patients with gastric cancer].
    Chen P; Chu YL; Song TS; Lei L; Wang JS; Wang K; Ni L; Niu YY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):852-5. PubMed ID: 17243293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.